Literature DB >> 7531042

Development after prenatal exposure to cocaine, heroin and methadone.

A L van Baar1, S Soepatmi, W B Gunning, G W Akkerhuis.   

Abstract

In Amsterdam a longitudinal, prospective and multidisciplinary study on the development of infants of drug-dependent mothers (IDDM) was started in 1983: 35 IDDM and 35 reference infants were originally enrolled. The drug-dependent women had used combinations of methadone, heroin, cocaine and other drugs during pregnancy. Of the IDDM, 80% had to be treated pharmaceutically for neonatal abstinence symptoms (NAS). Physical, neurological, cognitive and the socio-emotional development of the children were studied regularly from birth until 5.5 years of age. Differences between the reference group and the IDDM were found most clearly in cognitive development. The IDDM also had more behavioural problems at some of the ages studied. No group differences were seen in motor development. So far the results of the study show that IDDM and their caregivers need extra support in order to improve early communication and the children's cognitive development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531042     DOI: 10.1111/j.1651-2227.1994.tb13383.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  14 in total

Review 1.  Drug misusing parents: key points for health professionals.

Authors:  J Keen; L H Alison
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 2.  Consequences of prenatal toxin exposure for mental health in children and adolescents: a systematic review.

Authors:  Justin H G Williams; Louise Ross
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-01-02       Impact factor: 4.785

Review 3.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

4.  Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.

Authors:  Ana de Castro; Hendreé E Jones; Rolley E Johnson; Teresa R Gray; Diaa M Shakleya; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-08       Impact factor: 3.681

Review 5.  Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review.

Authors:  D A Frank; M Augustyn; W G Knight; T Pell; B Zuckerman
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

6.  The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination.

Authors:  Allison A Vestal-Laborde; Andrew C Eschenroeder; John W Bigbee; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Dev Neurosci       Date:  2014-08-19       Impact factor: 2.984

Review 7.  Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.

Authors:  T Lewis; J Dinh; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2015-07-22       Impact factor: 6.875

8.  [Addiction--who is not affected?].

Authors:  Andjela Bäwert; Gabriele Fischer
Journal:  Wien Med Wochenschr       Date:  2005-12

9.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

10.  Clinical features and correlates of outcomes for high-risk, marginalized mothers and newborn infants engaged with a specialist perinatal and family drug health service.

Authors:  Lee Taylor; Delyse Hutchinson; Ron Rapee; Lucy Burns; Christine Stephens; Paul S Haber
Journal:  Obstet Gynecol Int       Date:  2012-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.